Tenet Health(US:THC) ZACKS·2025-07-22 14:30Core Insights - Tenet Healthcare reported revenue of $5.27 billion for the quarter ended June 2025, marking a year-over-year increase of 3.3% and exceeding the Zacks Consensus Estimate by 2.43% [1] - The earnings per share (EPS) for the same period was $4.02, a significant increase from $2.31 a year ago, representing a surprise of 41.55% over the consensus estimate of $2.84 [1] Financial Performance Metrics - Adjusted admissions were reported at 211.52 thousand, below the two-analyst average estimate of 223.82 thousand [4] - Net Operating revenues were $5.27 billion, surpassing the average estimate of $5.13 billion based on four analysts, with a year-over-year change of 3.3% [4] - Net Operating revenues from Ambulatory Care reached $1.27 billion, exceeding the estimated $1.23 billion and reflecting an 11.3% increase compared to the previous year [4] - Hospital Operations and Services generated $4 billion in revenue, compared to the average estimate of $3.92 billion, indicating a 1% year-over-year change [4] - Equity in earnings of unconsolidated affiliates was $61 million, slightly above the average estimate of $60.53 million [4] - Adjusted EBITDA for Hospital Operations and Services was reported at $623 million, exceeding the average estimate of $505.06 million [4] - Adjusted EBITDA for Ambulatory Care was $498 million, slightly above the average estimate of $496.33 million [4] Stock Performance - Tenet's shares have returned 3.3% over the past month, compared to a 5.9% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]